Effect of von Willebrand Factor and Its Proteolytic Fragments on Kinetics of Interaction between the Light and Heavy Chains of Human Factor VIII - Pharmacokinetics and initial safety aspects in hemophilia A patients

By Saenko E.L.   Loster K.   Josic D.   Sarafanov A.G.  

Thrombosis Research, Vol. 96, Iss. 5, 1999-12 ,pp. : 343-354

Elsevier

Access to resources Recommend Favorite

A case of acquired hemophilia caused by factor VIII inhibitor with rheumatoid arthritis, successfully treated with immunosuppressive treatment and recombinant activated factor VII

By Sato Takeo   Hagiwara Kiyofumi   Chikazoe Junnichi   Nakagawa Yasunori   Akiyama Osamu  

Modern Rheumatology, Vol. 14, Iss. 4, 2004-09 ,pp. : 320-322

Springer Publishing Company

Access to resources Recommend Favorite

Immunological Characterization of Factor VIII Autoantibodies in Patients with Acquired Hemophilia A in the Presence or Absence of Underlying Disease

By Matsumoto T.   Shima M.   Fukuda K.   Nogami K.   Giddings J.C.   Murakami T.   Tanaka I.   Yoshioka A.  

Thrombosis Research, Vol. 104, Iss. 6, 2001-12 ,pp. : 381-388

Elsevier

Access to resources Recommend Favorite

A Kinetic Analysis of the Interaction of Human Recombinant Tissue Factor Pathway Inhibitor with Factor Xa Utilizing an Immunoassay and the Effect of Antithrombin III/Heparin on the Complex Formation - one N- and two O-linked carbohydrate chains are located between Kunitz domains 2 and 3 and one N-linked carbohydrate chain is in Kunitz domain 2

By Kamikubo Y.-i.   Hamuro T.   Takemoto S.   Nakahara Y.   Kamei S.   Nakagaki T.   Miyamoto S.   Funatsu A.   Kato H.  

Thrombosis Research, Vol. 89, Iss. 4, 1998-02 ,pp. : 179-186

Elsevier

Access to resources Recommend Favorite

Domain Specific Monoclonal Anti-factor VIII Antibodies Generated by Inclusion Body-renatured Factor VIII Peptides

By Huang C.-C.   Li L.-T.   Shen M.-C.   Chen  

Thrombosis Research, Vol. 101, Iss. 5, 2001-03 ,pp. : 405-415

Elsevier

Access to resources Recommend Favorite